B. Jagielska, “Assessment of efficacy of trastuzumab (Herceptin) comprising adjuvant therapy of HER2+ breast cancer patients determined based upon statistical analysis of overall survival (OS) and disease-free survival (PFS) ”, MCTM, vol. 6, no. 1, pp. 37–49, Mar. 2023.